The client, with an established national field sales footprint, looked to partner to improve the stagnant sales trajectory for their I/O delivery device.
A field team of 16 DSAs (diabetes representatives) was overlayed to existing team to support high and medium-value targets to improve impact and call frequency.
DSAs’ goals also included elevating brand perception not just to the targeted HCPs but through a total account call to maximize pull-through adjacent to clinical selling.
Within the first four months of the added team, high-value DSA targets were averaging 3.5 more Rxs per target compared to the control group.
Average DSA had 21% more call activity (and 12% more sampling) than incumbent team.
Call activity (reach and frequency) was improved while contributing to a significant improvement in the cost per call (82% savings) for DSA targets.
Qualitative (market effectiveness surveys) feedback also showed improved brand and message recall and DSA satisfaction.
Wave 1:
93% of respondents state that they are ‘very satisfied’ with their DSA.**
**7% state that they are ‘satisfied’.
Jump to a slide with the slide dots.
CASE STUDY (US) Strategic partnership to re-evaluate resources required to drive quality and execution
Read more
CASE STUDY (US) Flexibility and impact through Rapid Deployment Representative specialty team.
Read more
CASE STUDY (Canada) See how Inizio Engage helped a leading OTC brand protect market share and drive HCP advocacy through targeted field and virtual...
Read more
Discover how partnership-led pharma commercialization strategies drive better HCP engagement, agility, and performance in an AI-enabled world.
Read more